Equine influenza virus

Veterinary Clinics of North America - Equine Practice

Volumn 30, Issue 3, 2014, Pages 507-522

  Landolt, Gabriele A ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Control; Diagnosis; Epidemiology; Influenza A virus; Virus evolution

Indexed keywords

EQUINE INFLUENZA VIRUS; INFLUENZA A VIRUS;

INFLUENZA VACCINE;

ANIMAL; DOG; DOG DISEASE; GENETICS; HORSE; HORSE DISEASES; IMMUNOLOGY; INFLUENZA VIRUS A; ISOLATION AND PURIFICATION; ORTHOMYXOVIRIDAE INFECTIONS; VETERINARY; VIROLOGY;

ANIMALS; DOG DISEASES; DOGS; HORSE DISEASES; HORSES; INFLUENZA A VIRUS; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84922265180     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2014.08.003     Document Type: Review

References (102)

1. Webster R.G., Bean W.J., Gorman O.T., et al. Evolution and ecology of influenza A viruses. Microbiol Rev 1992, 56:152-179.
2. McMichael A.J., Michie C.A., Gotch F.M., et al. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. JGen Virol 1986, 67:719-726.
3. Hemann E.A., Kang S.M., Legge K.L. Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination. JImmunol 2013, 191:2486-2494.
4. McKinstry K.K., Dutton R.W., Swain S.L., et al. Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful. Arch Immunol Ther Exp 2013, 61:341-353.
5. Daly J.M., Yates P.J., Newton J.R., et al. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines. Vaccine 2004, 22:4101-4109.
6. Daly J.M., Yates R.J., Browse G., et al. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Vet J 2003, 35:458-462.
7. Newton J.R., Lakhani K.H., Wood J.L., et al. Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine. Prev Vet Med 2000, 46:129-141.
8. Newton J.R., Verheyen K., Wood J.L., et al. Equine influenza in the United Kingdom in 1998. Vet Rec 1999, 145:449-452.
9. Barquero N., Daly J.M., Newton J.R. Risk factors for influenza infection in vaccinated racehorses: lessons from an outbreak in Newmarket, UK in 2003. Vaccine 2007, 25:7520-7529.
10. Burrows R., Goodridge D., Denyer M., et al. Equine influenza infections in Great Britain, 1979. Vet Rec 1982, 110:494-497.
11. Elton D., Cullinane A. Equine influenza: antigenic drift and implications for vaccines. Equine Vet J 2013, 45:768-769.
12. Mumford JA, Wood J, Chambers T. Consultation of OIE and WHO experts on progress in surveillance of equine influenza and application to vaccine strain selection. In Report of a meeting held at the Animal Health Trust. Newmarket (United Kingdom), September 18-19, 1995.
13. Lai A.C., Chambers T.M., Holland R.E., et al. Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Arch Virol 2001, 146:1063-1074.
14. Bryant N.A., Rash A.S., Russell C.A., et al. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet Microbiol 2009, 138:41-52.
15. Bryant N.A., Rash A.S., Woodward A.L., et al. Isolation and characterization of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009. Vet Microbiol 2011, 147:19-27.
16. Gildea S., Quinlivan M., Arkins S., et al. The molecular epidemiology of equine influenza in Ireland from 2007-2010 and its international significance. Equine Vet J 2012, 44:387-392.
17. Watson J., Halpin K., Selleck P., et al. Isolation and characterization of an H3N8 equine influenza virus in Australia, 2007. Aust Vet J 2011, 89:35-37.
18. King E.L., MacDonald D. Report to the Board of Inquiry appointed by the Board of the National Horseracing Authority to conduct enquiry into the causes of the equine influenza with started in the Western cape in early December 2003 and spread to the Eastern Cape and Gauteng. Aust Vet J 2004, 23:139-142.
19. Yamanaka T., Niwa H., Tsujimura K., et al. Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. JVet Med Sci 2008, 70:623-625.
20. Legrand L.J., Pitel P.H., Marcillaud-Pitel C.J., et al. Surveillance of equine influenza viruses through the RESPE network in France from November 2005 to October 2010. Equine Vet J 2013, 45:776-783.
21. Woodward A.L., Rash A.S., Blinman D., et al. Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012. Vet Microbiol 2014, 169:113-127.
22. Laabassi F., Lecouturier F., Amelot G., et al. Epidemiology and genetic characterization of H3N8 equine influenza virus responsible for clinical disease in Algeria in 2011. Transbound Emerg Dis 2014, [Epub ahead of print].
23. Bera B.C., Virmani N., Shanmugasundaram K., et al. Genetic analysis of the neuraminidase (NA) gene of equine influenza virus (H3N8) from epizootic of 2008-2009 in India. Indian J Virol 2013, 24:256-264.
24. Yondon M., Heil G.L., Burks J.P., et al. Isolation and characterization of H3N8 equine influenza A virus associated with the 2011 epizootic in Mongolia. Influenza Other Respir Viruses 2013, 7:659-665.
25. Zhu C., Li Q., Guo W., et al. Complete genomic sequences of an H3N8 equine influenza virus strain isolated in China. Genome Announc 2013, 1.
26. Webster R.G. Are equine 1 influenza viruses still present in horses?. Equine Vet J 1993, 25:537-538.
27. Ito T., Kawaoka Y. Host-range barrier of influenza A viruses. Vet Microbiol 2000, 74:71-75.
28. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000, 69:531-569.
29. Crawford P.C., Dubovi E.J., Castleman W.L., et al. Transmission of equine influenza virus to dogs. Science 2005, 310:482-485.
30. Daly J.M., Blunden A.S., MacRae S., et al. Transmission of equine influenza virus to English foxhounds. Emerg Infect Dis 2008, 14:461-464.
31. Newton J.R., Cooke A., Elton D., et al. Canine influenza virus: cross-species transmission from horses. Vet Rec 2007, 161:142-143.
32. Kirkland P.D., Finlaison D.S., Crispe E., et al. Influenza virus transmission from horses to dogs, Australia. Emerg Infect Dis 2010, 16:699-702.
33. Yamanaka T., Nemoto M., Tsujimura K., et al. Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses. Vet Microbiol 2009, 139:351-355.
34. Pecoraro H.L., Bennett S., Garretson K., et al. Comparison of the infectivity and transmission of contemporary canine and equine H3N8 influenza viruses in dogs. Vet Med Int 2013, 2013:874521. 10.1155/2013/874521.
35. Suzuki Y., Ito T., Suzuki T., et al. Sialic acid species as a determinant of the host range of influenza A viruses. JVirol 2000, 74:11825-11831.
36. Yamanaka T., Tsujimura K., Kondo T., et al. Infectivity and pathogenicity of canine H3N8 influenza A virus in horses. Influenza Other Respir Viruses 2010, 4:345-351.
37. Quintana A.M., Hussey S.B., Burr E.C., et al. Evaluation of infectivity of a canine lineage H3N8 influenza A virus in ponies and in primary equine respiratory epithelial cells. Am J Vet Res 2011, 72:1071-1078.
38. Nyaga P.N., Wiggins A.D., Priester W.A. Epidemiology of equine influenza, risk by age, breed and sex. Comp Immunol Microbiol Infect Dis 1980, 3:67-73.
39. Peek S.F., Landolt G., Karasin A.I., et al. Acute respiratory distress syndrome and fatal interstitial pneumonia associated with equine influenza in a neonatal foal. JVet Intern Med 2004, 18:132-134.
40. Smith B.P. Influenza in foals. JAm Vet Med Assoc 1979, 174:289-290.
41. Happold J., Rubira R. Equine influenza: patterns of disease and seroprevalence in Thoroughbred studs and implications for vaccination. Aust Vet J 2011, 89(Suppl 1):135-137.
42. Heldens J.G., Pouwels H.G., van Loon A.A. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95). Vet J 2004, 167:150-157.
43. Mumford J.A., Jessett D., Dunleavy U., et al. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 1994, 12:857-863.
44. Mumford J.A., Wood J.M., Folkers C., et al. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus. Epidemiol Infect 1988, 100:501-510.
45. Mumford J.A., Wood J.M., Scott A.M., et al. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). JHyg (Lond) 1983, 90:385-395.
46. Newton J.R., Townsend H.G., Wood J.L., et al. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J 2000, 32:65-74.
47. Morley P.S., Townsend H.G., Bogdan J.R., et al. Risk factors for disease associated with influenza virus infections during three epidemics in horses. JAm Vet Med Assoc 2000, 216:545-550.
48. Morley P.S., Townsend H.G., Bogdan J.R., et al. Descriptive epidemiologic study of disease associated with influenza virus infections during three epidemics in horses. JAm Vet Med Assoc 2000, 216:535-544.
49. Bridges C.B., Kuehnert M.J., Hall C.B. Transmission of influenza: implications for control in health care settings. Clin Infect Dis 2003, 37:1094-1101.
50. Boone S.A., Gerba C.P. The occurrence of influenza A virus on household and day care center fomites. JInfect 2005, 51:103-109.
51. Firestone S.M., Cogger N., Ward M.P., et al. The influence of meteorology on the spread of influenza: survival analysis of an equine influenza (A/H3N8) outbreak. PLoS One 2011, 7:e35284.
52. Newton J.R., Daly J.M., Spencer L., et al. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet Rec 2006, 158:185-192.
53. van Maanen C., Bruin G., de Boer-Luijtze E., et al. Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza. Vet Q 1992, 14:13-17.
54. Van Oirschot J.T., Bruin G., de Boer-Luytze E., et al. Maternal antibodies against equine influenza virus in foals and their interference with vaccination. Zentralbl Veterinarmed B 1991, 38:391-396.
55. Wilson W.D., Mihalyi J.E., Hussey S., et al. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet J 2001, 33:644-650.
56. Guthrie AJ. Equine influenza in South Africa, 2003 outbreak. In 9th International Congress of World Equine Veterinary Association. International Veterinary Information Service. Marrakech, Morrocco, January 22-26, 2006.
57. Virmani N., Bera B.C., Gulati B.R., et al. Descriptive epidemiology of equine influenza in India (2008-2009): temporal and spatial trends. Vet Ital 2010, 46:449-458.
58. Callinan I. Equine influenza: The August 2007 outbreak in Australia. Report of the Equine Influenza Inquiry. 2008. Available at: http://pandora.nla.gov.au/pan/47126/20100421-1408/www.aph.gov.au/library/intguide/law/eiiexhibits/REP.0001.001.0001.pdf.
59. Lunn D.P., Townsend H.G. Equine vaccination. Vet Clin North Am Equine Pract 2000, 16:199-226.
60. Daly J.M., Newton J.R., Mumford J.A. Current perspectives on control of equine influenza. Vet Res 2004, 35:411-423.
61. van Maanen C., Cullinane A. Equine influenza virus infections: an update. Vet Q 2002, 24:79-94.
62. Firestone S.M., Schemann K.A., Toribio J.A., et al. Acase-control study of risk factors for equine influenza spread onto horse premises during the 2007 epidemic in Australia. Prev Vet Med 2011, 100:53-63.
63. Garner M.G., Scanlan W.A., Cowled B.D., et al. Regaining Australia's equine influenza-free status: a national perspective. Aust Vet J 2011, 89:169-173.
64. Scott-Orr H. Proof of freedom from equine influenza infection in Australia in 2007-08. Aust Vet J 2011, 89:163-164.
65. Schemann K., Firestone S.M., Taylor M.R., et al. Horse owners'/managers' perceptions about effectiveness of biosecurity measures based on their experiences during the 2007 equine influenza outbreak in Australia. Prev Vet Med 2012, 106:97-107.
66. Bish A., Michie S. Demographic and attitudinal determinants of protective behaviours during a pandemic: a review. Br J Health Psychol 2010, 15:797-824.
67. Schemann K., Taylor M.R., Toribio J.A., et al. Horse owners' biosecurity practices following the first equine influenza outbreak in Australia. Prev Vet Med 2011, 102:304-314.
68. Lin C., Holland R.E., Donofrio J.C., et al. Caspase activation in equine influenza virus induced apoptotic cell death. Vet Microbiol 2002, 84:357-365.
69. Lin C., Zimmer S.G., Lu Z., et al. The involvement of a stress-activated pathway in equine influenza virus-mediated apoptosis. Virology 2001, 287:202-213.
70. Schultz-Cherry S., Dybdahl-Sissoko N., Neumann G., et al. Influenza virus ns1 protein induces apoptosis in cultured cells. JVirol 2001, 75:7875-7881.
71. Wilson W.D. Equine influenza. Vet Clin North Am Equine Pract 1993, 9:257-282.
72. Coggins L. Viral respiratory disease. Vet Clin North Am Large Anim Pract 1979, 1:59-72.
73. Gerber H. Clinical features, sequelae and epidemiology of equine influenza. Equine infectious disease 1969, 63-80. Karger, New York. 2nd edition. J.T. Bryans, H. Gerber (Eds.).
74. Willoughby R., Ecker G., McKee S., et al. The effects of equine rhinovirus, influenza virus and herpesvirus infection on tracheal clearance rate in horses. Can J Vet Res 1992, 56:115-121.
75. Wright P.F., Webster R.G. Orthomyxoviruses. Field's virology 2007, 1647-1690. Lippincott-Raven, Philadelphia. D. Knipe, P.M. Howley (Eds.).
76. Hall W.J., Douglas R.G., Hyde R.W., et al. Pulmonary mechanics after uncomplicated influenza A infection. Am Rev Respir Dis 1976, 113:141-148.
77. Alexander D.J., Brown I.H. Recent zoonoses caused by influenza A viruses. Rev Sci Tech 2000, 19:197-225.
78. Gilkerson J.R. Equine influenza in Australia: a clinical overview. Aust Vet J 2011, 89(Suppl 1):11-13.
79. Powell D.G. Viral respiratory disease of the horse. Vet Clin North Am Equine Pract 1991, 7:27-52.
80. Daly J.M., Whitwell K.E., Miller J., et al. Investigation of equine influenza cases exhibiting neurological disease: coincidence or association?. JComp Pathol 2006, 134:231-235.
81. Newland J.G., Laurich V.M., Rosenquist A.W., et al. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. JPediatr 2007, 150:306-310.
82. Steininger C., Popow-Kraupp T., Laferl H., et al. Acute encephalopathy associated with influenza A virus infection. Clin Infect Dis 2003, 36:567-574.
83. Lamb R, Krug R. Orthomyxoviruses: the viruses and their replication. In: Knipe D, Howley PM, editors. Field's virology. Philadelphia: Lippincott-Raven Publishers; p. 1691-740.
84. Adam E.N., Morley P.S., Chmielewski K.E., et al. Detection of cold-adapted vaccine-strain influenza virus using two commercial assays. Equine Vet J 2002, 34:400-404.
85. Chambers T.M., Shortridge K.F., Li P.H., et al. Rapid diagnosis of equine influenza by the Directigen FLU-A enzyme immunoassay. Vet Rec 1994, 135:275-279.
86. Livesay G.J., O'Neill T., Hannant D., et al. The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA. Vet Rec 1993, 133:515-519.
87. Morley P.S., Bogdan J.R., Townsend H.G., et al. Evaluation of Directigen Flu A assay for detection of influenza antigen in nasal secretions of horses. Equine Vet J 1995, 27:131-134.
88. Diallo I.S., Read A.J., Kirkland P.D. Potential of vaccination to confound interpretation of real-time PCR results for equine influenza. Vet Rec 2011, 169:252.
89. Foord A.J., Selleck P., Colling A., et al. Real-time RT-PCR for detection of equine influenza and its evaluation using samples from horses infected with A/equine/Sydney/2007 (H3N8). Aust Vet J 2009, 89(Suppl 1):37-38.
90. Soboll G., Hussey S.B., Minke J.M., et al. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination. Vet Immunol Immunopathol 2010, 135:100-107.
91. Pusterla N., Madigan J.E., Leutenegger C.M. Real-time polymerase chain reaction: a novel molecular diagnostic tool for equine infectious diseases. JVet Intern Med 2006, 20:3-12.
92. Ozaki H., Sugiura T., Sugita S., et al. Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses. Vet Microbiol 2001, 82:111-119.
93. Birch-Machin I., Rowan A., Pick J., et al. Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera. JVirol Methods 1997, 65:255-263.
94. Nakajima K., Nobusawa E., Nakajima S. Evolution of the NS genes of the influenza A viruses. II. Characteristics of the amino acid changes in the NS1 proteins of the influenza A viruses. Virus Genes 1990, 4:15-26.
95. Kirkland P.D., Delbridge G. Use of a blocking ELISA for antibodies to equine influenza virus as a test to distinguish between naturally infected and vaccinated horses: proof of concept studies. Aust Vet J 2011, 89:45-46.
96. Perkins N.R., Webster R.G., Wright T., et al. Vaccination program in the response to the 2007 equine influenza outbreak in Australia. Aust Vet J 2011, 89:126-134.
97. Kirkland P.D. Role of the diagnostic laboratories during the 2007 equine influenza outbreak in Australia. Aust Vet J 2011, 89(Suppl 1):29-32.
98. Sergeant E.S., Cowled B.D., Bingham P. Diagnostic specificity of an equine influenza blocking ELISA estimated from New South Wales field data from the Australian epidemic in 2007. Aust Vet J 2011, 89(Suppl 1):43-45.
99. Myers C., Wilson W.D. Equine influenza virus. Clin Tech Equine Pract 2006, 5:187-196.
100. Paillot R., Hannant D., Kydd J.H., et al. Vaccination against equine influenza: quid novi?. Vaccine 2006, 24:4047-4061.
101. Townsend HG, Lunn DP, Bogdan J, etal. Comparative efficacy of commercial vaccines in naive horses: serologic responses and protection after influenza challenge. In 49th Annual AAEP Convention, American Association of Equine Practitioners. New Orleans, 2003. November 21-25, 2003.
102. Park A.W., Wood J.L., Newton J.R., et al. Optimising vaccination strategies in equine influenza. Vaccine 2003, 21:2862-2870.